MRI contrast developer Epix Medical has started a private offering of up to $75 million in convertible senior notes available only to qualified institutional buyers, according to the Cambridge, MA-based firm.
The company said it expects to grant the initial purchasers a 30-day option to buy up to an additional $25 million in notes.
By AuntMinnie.com staff writersJune 2, 2004
Related Reading
Epix trims losses in Q1, April 30, 2004
Epix names McMurry as research VP, March 12, 2004
Epix loss falls, sales rise in 2003, February 18, 2004
Epix gets U.S. patent for MS-325, January 13, 2004
Epix submits MR contrast agent for FDA approval, December 16, 2003
Copyright © 2004 AuntMinnie.com
